Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2KRI

Structure of a complex between domain V of beta2-glycoprotein I and the fourth ligand-binding module from LDLR determined with Haddock

Summary for 2KRI
Entry DOI10.2210/pdb2kri/pdb
NMR InformationBMRB: 16639
DescriptorBeta-2-glycoprotein 1, Low-density lipoprotein receptor, CALCIUM ION (3 entities in total)
Functional Keywordsantiphospholipid syndrome, thrombosis, ldlr, receptor, disulfide bond, glycoprotein, heparin-binding, sushi, protein binding-endocytosis complex, protein binding/endocytosis
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight14017.92
Authors
Beglova, N. (deposition date: 2009-12-18, release date: 2010-03-31, Last modification date: 2024-10-16)
Primary citationLee, C.J.,De Biasio, A.,Beglova, N.
Mode of interaction between beta2GPI and lipoprotein receptors suggests mutually exclusive binding of beta2GPI to the receptors and anionic phospholipids.
Structure, 18:366-376, 2010
Cited by
PubMed Abstract: Lipoprotein receptors of the LDLR family serve as clearance receptors for beta2GPI and as signaling receptors for the beta2GPI/antibody complexes in antiphospholipid syndrome. We compared four ligand-binding LA modules from LDLR and ApoER2 for their ability to bind domain V of beta2GPI (beta2GPI-DV). We found that the LA modules capable of binding beta2GPI-DV interact with the same region on beta2GPI-DV using residues at their calcium-coordination site. The structure of a complex between beta2GPI-DV and LA4 of LDLR, solved by molecular docking guided by NMR-derived restraints and extensively validated, represents the general mode of interaction between beta2GPI and lipoprotein receptors. We have shown that beta2GPI-DV cannot simultaneously bind to lipoprotein receptors and anionic phospholipids, suggesting that the association of beta2GPI/anti-beta2GPI antibody complexes with anionic phospholipids will interfere with lipoprotein receptors' signaling in APS.
PubMed: 20223219
DOI: 10.1016/j.str.2009.12.013
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon